Takeda unit urges Fed Circ to revive antibody patent

Baxalta, a subsidiary of Japan-headquartered pharmaceutical company Takeda, has asked the US Court of Appeals for the Federal Circuit to overturn a decision that invalidated its antibody patent.

Related Keywords

,Genentech ,Axalta ,Emlibra ,Haemophilia ,Takada ,Antibodies ,Patent Infringement ,